GlycoFlux™ Human SIGLEC8 Overexpression HEK293 Cell Line (CAT#: GLJF-0925-JF906)

Description	GlycoFlux™ human SIGLEC8 overexpression HEK293 cell line is a stable system engineered for SIGLEC8 expression, providing a tractable platform to analyze ITIM-mediated inhibitory signaling and SLAM-like adaptor protein recruitment. As a hematopoietic receptor expressed in eosinophils and mast cells, SIGLEC8 plays roles in allergic responses and immune suppression, making this line valuable for immunology and therapeutic discovery.
Product Type	Overexpression Cell Lines
Species	Human
Cell Morphology	Epithelial-like, adherent
Passage Ratio	1:2~1:4
Cell Line	HEK293
Lineage	Embryonic kidney

Cell Viability	>90%
Sterility Test	The sterility test indicated an absence of microbial growth.
Identity Test	STR identification
Mycoplasma Test	Negative
Virus Test	Negative for HIV, HBV and HCV.
Genetic Stability Testing	We conduct cell genetic stability studies in full compliance with ICH guidelines. Our expertise enables us to design and execute a comprehensive testing program tailored to your specific needs and regulatory requirements.
Validation	qPCR, Sanger Sequencing
Culture Medium	FBS & Penicillin/Streptomycin & Proline & DMEM
Application	Mechanistic studies; Exploration of glycosylation and signaling pathways in cancer, metabolic, and immune-related diseases; Drug target validation and other functional assays.
Size	1 M cells/vial*2
Product Format	Frozen
Shipping	Dry ice
Availability Status	Made to order
Handling Notes	Upon receipt, this product must be immediately transferred from dry ice to liquid nitrogen (-150°C to -190°C) and stored in a liquid nitrogen tank. Cell viability is critically dependent on proper handling. We cannot guarantee viability if these instructions are not strictly adhered to.
Product Disclaimer	This product is provided for research only, not suitable for human or animal use. Due to the inherent limitations of infectious agent testing, investigators must exercise extreme caution when handling cells provided by Creative Biolabs, treating all cells as potentially biohazardous.

Target	SIGLEC8
Full Name	Sialic Acid Binding Ig Like Lectin 8
Alternative Name	SAF2, SIGLEC-8, SIGLEC8L, Sialic Acid Binding Ig Like Lectin
Location	19q13.33-q13.41
Gene ID	27181
Summary	SIGLECs, including SIGLEC8, are type I transmembrane proteins that exhibit unique expression patterns, mainly in hematopoietic cells. SIGLEC8, located at 19q13.3-q13.4, contains conserved cytoplasmic motifs: an immunoreceptor tyrosine-based inhibitory motif (ITIM) and a SLAM-like motif that interacts with SLAM-associated protein (SAP).